Clinical Research Detail Title Of Study A Randomized, Double-Blind, Placebo- and Sitagliptin-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment Including Subjects on Hemodialysis Disease Condition Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment Phase of Trial Phase-3 Discipline Diabetology Start date of Trial 8/1/2009 Closing Date of Trial 8/1/2011 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]